| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.20B | $871.7M | $614.5M |
| YoY Revenue Growth % | +37.3% | +41.9% | — |
| Gross Profit | $296.3M | $238.2M | — |
| Gross Margin % | 24.8% | 27.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $75.5M | $44.9M | $18.1M |
| Operating Margin % | 6.3% | 5.1% | 2.9% |
| Net Income (GAAP) | $66.9M | $44.2M | $22.3M |
| EBITDA (Normalized) | $75.8M | $45.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $162.1M | $63.6M | $68.8M |
| Capital Expenditures (CapEx) | $361.0K | $457.0K | — |
| Free Cash Flow (FCF) | $161.8M | $63.2M | $68.8M |
| FCF Margin % | 13.5% | 7.2% | 11.2% |
| Return on Invested Capital (ROIC %) | 24.9% | 12.7% | — |
| Cash & Short-Term Equivalents | $320.9M | $205.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $560.4M | $485.6M | — |